As of September 2024, Arovella Therapeutics has a market cap of $69.15M. This makes Arovella Therapeutics the world's 21855th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $85.84M | 56.52% |
2023 | $54.84M | 400.00% |
2022 | $10.97M | -41.03% |
2021 | $18.60M | -2.50% |
2020 | $19.08M | -18.60% |
2019 | $23.44M | -59.30% |
2018 | $57.58M | -59.09% |
2017 | $140.74M | -15.79% |
2016 | $167.13M | -29.63% |
2015 | $237.50M | -54.24% |
2014 | $518.99M | -24.36% |
2013 | $686.12M | 129.41% |
2012 | $299.08M | 61.90% |
2011 | $184.73M | -58.82% |
2010 | $448.62M | -32.00% |
2009 | $659.73M | 2.89% |
2008 | $641.17M | -54.44% |
2007 | $1.41B | 44.00% |
2006 | $977.39M | 0.00% |
2005 | $977.39M | -44.44% |
2004 | $1.76B | -52.94% |
2003 | $3.74B | 145.20% |
2002 | $1.52B | - |